NewslettersHematopoiesis NewsUncategorizedNovel Therapeutics and Targets in MyelofibrosisBy Justin.choi - December 7, 20210100Scientists discuss the limitations of currently approved treatment options and novel therapeutic targets with drug candidates in late-stage, Phase II or III, clinical development for the treatment of myelofibrosis.[Leukemia & Lymphoma] 6445212 BBBBBBBB items 1 apa 0 default asc 1 169805 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/Abstract